Sorrento Therapeutics, Inc. (SRNEQ)
OTCMKTS: SRNEQ · Delayed Price · USD
0.0300
+0.0010 (3.45%)
Apr 12, 2024, 3:52 PM EDT - Market closed
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $16.54 million as of April 18, 2024. Its market cap has decreased by -98.19% in one year.
Market Cap
16.54M
Enterprise Value
452.43M
1-Year Change
-98.19%
Ranking
n/a
Category
Stock Price
$0.03
Market Cap Chart
Since March 21, 2007, Sorrento Therapeutics's market cap has decreased from $23.59B to $16.54M, a decrease of -99.93%. That is a compound annual growth rate of -36.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 22, 2023 | 144.90M | -20.25% |
Feb 21, 2023 | 181.70M | 24.20% |
Feb 17, 2023 | 146.30M | 20.21% |
Feb 16, 2023 | 121.70M | 56.23% |
Feb 15, 2023 | 77.90M | -16.60% |
Feb 14, 2023 | 93.40M | -23.00% |
Feb 13, 2023 | 121.30M | -72.66% |
Feb 10, 2023 | 443.60M | 0.66% |
Feb 9, 2023 | 440.70M | -5.08% |
Feb 8, 2023 | 464.30M | -6.30% |
Feb 7, 2023 | 495.50M | 0.96% |
Feb 6, 2023 | 490.80M | 1.97% |
Feb 3, 2023 | 481.30M | - |
Feb 2, 2023 | 481.30M | 6.25% |
Feb 1, 2023 | 453.00M | 0.11% |
Jan 31, 2023 | 452.50M | 0.94% |
Jan 30, 2023 | 448.30M | -5.94% |
Jan 27, 2023 | 476.60M | 5.21% |
Jan 26, 2023 | 453.00M | -4.95% |
Jan 25, 2023 | 476.60M | - |
Jan 24, 2023 | 476.60M | -5.61% |
Jan 23, 2023 | 504.90M | -1.83% |
Jan 20, 2023 | 514.30M | -6.05% |
Jan 19, 2023 | 547.40M | -2.51% |
Jan 18, 2023 | 561.50M | 2.58% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 709.98B |
Novo Nordisk | 557.20B |
UnitedHealth Group | 432.29B |
Johnson & Johnson | 347.95B |
Merck & Co. | 316.73B |
AbbVie | 287.80B |
Thermo Fisher | 211.68B |
AstraZeneca | 211.61B |